Guaifenesin and Device failure - a phase IV clinical study of FDA data

Summary:

Device failure is reported as a side effect among people who take Guaifenesin (guaifenesin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Device failure when taking Guaifenesin. It is created by eHealthMe based on reports of 11,942 people who have side effects when taking Guaifenesin from the FDA, and is updated regularly.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.

What is Device failure?

Device failure is found to be associated with 750 drugs and 761 conditions by eHealthMe. Check the latest studies of Device failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

11,942 people reported to have side effects when taking Guaifenesin.
Among them, 12 people (0.1%) have Device failure.

Among these 12 people:

How long have people been on Guaifenesin when they have Device failure? *

What is the gender of people who have Device failure when taking Guaifenesin? *

female: 75 %
male: 25 %

What is the age of people who have Device failure when taking Guaifenesin? *

What are other drugs people take besides Guaifenesin? *

What are other side effects people have besides Device failure? *

Dyspnea Exertional: 4 people, 33.33%
Infusion Site Pain: 3 people, 25.00%
Infusion Site Haemorrhage (bleeding from infusion site): 3 people, 25.00%
Neuralgia (pain in one or more nerves): 2 people, 16.67%
Hypotension (abnormally low blood pressure): 2 people, 16.67%
Infusion Site Erythema (reddening of the skin at infusion site): 2 people, 16.67%
Infusion Site Irritation: 2 people, 16.67%
Infusion Site Pruritus (severe itching at infusion site): 2 people, 16.67%
Infusion Site Rash: 2 people, 16.67%
Infusion Site Reaction: 2 people, 16.67%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 33.33%
Constipation: 3 people, 25.00%
Abdominal Abscess (collection of pus in abdomen): 2 people, 16.67%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 16.67%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 2 people, 16.67%
Device Related Infection: 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Dry Mouth: 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Calcium Deficiency (lack of calcium): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Guaifenesin and have Device failure?

- Check whether Device failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Guaifenesin:

Guaifenesin (12,106 reports)

Device failure treatments and more:

Device failure (17,275 reports)

Browse all side effects of Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device failure:

Device failure (750 drugs)

Browse all the conditions that are associated with Device failure:

Device failure (761 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin (the active ingredients of Guaifenesin) and Guaifenesin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.